Vladimir Avramovic

Vladimir Avramovic

Auto-generated profile, based on publicly available information

Vladimir Avramovic

Department of Neurobiology, Institute for Biological Research, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Neurochemistry International
Verified
Journal Article
Closed access
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
DMDesanka Milanović
Desanka Milanović
VPVesna Pešić
Vesna Pešić
VTVesna Tešić
Vesna Tešić
MBMarjana Brkić
Marjana Brkić
SKSelma Kanazir
Selma Kanazir

24 April 2017 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
DMDesanka Milanovic
Desanka Milanovic
VPVesna Pešić
Vesna Pešić
NLNatasa Loncarevic-Vasiljkovic
Natasa Loncarevic-Vasiljkovic
VAVladimir Avramovic
Vladimir Avramovic
VTVesna Tesic
Vesna Tesic
SRSabera Ruzdijic
Sabera Ruzdijic

6 September 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
DMDesanka Milanovic
Desanka Milanovic
SPSnjezana Petrovic
Snjezana Petrovic
MBMarjana Brkic
Marjana Brkic
VAVladimir Avramovic
Vladimir Avramovic
MPMilka Perovic
Milka Perovic
SKSelma Kanazir
Selma Kanazir
Long-term fish oil (FO) supplementation is able to improve Alzheimer’s disease (AD) pathology. We aimed to determine the impact of short-term fish oil (FO) intake on phospholipids composition and plaque pathology in 5xFAD mice, a widely used animal model of AD. A 3-week-long FO supplementation administered at 3 months of age decreased the number of dense core plaques in the 5xFAD cortex and changed phospholipids in the livers and brains of wild-type (Wt) and 5xFAD mice. Livers of both genotypes responded by increase of n-3 and reciprocal decrease of n-6 fatty acids. In Wt brains, FO supplementation induced elevation of n-3 fatty acids and subsequent enhancement of n-6/n-3 ratio. However, in 5xFAD brains the improved n-6/n-3 ratio was mainly due to FO-induced decrease in arachidonic and adrenic n-6 fatty acids. Also, brain and liver abundance of n-3 fatty acids were strongly correlated in Wts, oppositely to 5xFADs where significant brain-liver correlation exists only for n-6 fatty acids. Expression of omega-3 transporter Mfs2a remained unchanged after FO supplementation. We have demonstrated that even a short-term FO intake improves the phospholipid composition and has a significant effect on plaque burden in 5xFAD brains when applied in early stages of AD pathology.

27 February 2024 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
KRK. M. Tahsin Hassan Rahit
K. M. Tahsin Hassan Rahit
VAVladimir Avramovic
Vladimir Avramovic
JCJessica X. Chong
Jessica X. Chong
MTMaja Taralo-Graovac
Maja Taralo-Graovac
Background: Thousands of genes have been associated with different Mendelian conditions. One of the valuable sources to track these gene-disease associations (GDAs) is the Online Mendelian Inheritance in Man (OMIM) database. However, most of the information in OMIM is textual, and heterogeneous (e.g. summarized by different experts), which complicates automated reading and understanding of the data. Here, we used Natural Language Processing (NLP) to make a tool (Gene-Phenotype Association Discovery (GPAD)) that could syntactically process OMIM text and extract the data of interest. Results: GPAD applies a series of language-based techniques to the text obtained from OMIM API to extract GDA discovery-related information. GPAD can inform when a particular gene was associated with a specific phenotype, as well as the type of validation—whether through model organisms or cohort-based patient-matching approaches—for such an association. GPAD extracted data was validated with published reports and was compared with large language model. Utilizing GPAD's extracted data, we analysed trends in GDA discoveries, noting a significant increase in their rate after the introduction of exome sequencing, rising from an average of about 150–250 discoveries each year. Contrary to hopes of resolving most GDAs for Mendelian disorders by now, our data indicate a substantial decline in discovery rates over the past five years (2017–2022). This decline appears to be linked to the increasing necessity for larger cohorts to substantiate GDAs. The rising use of zebrafish and Drosophila as model organisms in providing evidential support for GDAs is also observed. Conclusions: GPAD’s real-time analyzing capacity offers an up-to-date view of GDA discovery and could help in planning and managing the research strategies. In future, this solution can be extended or modified to capture other information in OMIM and scientific literature.